Supply Chain Constraints ‘Will Limit Vascepa Threat’

Dr Reddy’s And Hikma Have Path To Market

 
• By Dean Rudge
Drugs question mark
Will Reddy's, Hikma or other ANDA sponsors struggle with icosapent ethyl supply? • Source: Shutterstock

More from Manufacturing

More from Business